Dr. Harvey, PharmD, is Professor in the Department of Hematology and Medical Oncology with a joint appointment in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine. He serves as director of Winship Cancer Institute’sPhase I Clinical Trials Unitand as chair of theData and Safety Monitoring Committee. Dr. Harvey is a Fellow of the American College of Clinical Pharmacy and a Fellow of the Hematology/Oncology Pharmacy Association. He has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. Dr. Harvey is also active nationally and internationally in several cancer and pharmacology professional organizations. He is a past President of the Hematology and Oncology Pharmacy Association, an international professional organization. Dr. Harvey obtained his BS Pharmacy and Doctor of Pharmacy degrees at the University of North Carolina at Chapel Hill (UNC). He completed subsequent training at the University of Kentucky Medical Center and School of Pharmacy. Dr. Harvey specialized in Hematology/Oncology at UNC, where he was on staff and faculty for 8 years prior to coming to Grady Hospital in Atlanta, where he served as a clinical specialist in hematology and oncology and director of the hematology and oncology residency program.